{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:41:53Z","timestamp":1789965713584,"version":"4.0.1"},"reference-count":248,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Clinicians accept that there are many unknowns when we make diagnostic and therapeutic decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside decisions must often be made on the basis of incomplete evidence. Over the years, physicians sometimes even do not realize anymore which the fundamental gaps in our knowledge are. As clinical scientists, however, we have to halt and consider what we do not know yet, and how we can move forward addressing those unknowns. The European Heart Rhythm Association (EHRA) believes that scanning the field of arrhythmia \/ cardiac electrophysiology to identify knowledge gaps which are not yet the subject of organized research, should be undertaken on a regular basis. Such a review (White Paper) should concentrate on research which is feasible, realistic, and clinically relevant, and should not deal with futuristic aspirations. It fits with the EHRA mission that these White Papers should be shared on a global basis in order to foster collaborative and needed research which will ultimately lead to better care for our patients. The present EHRA White Paper summarizes knowledge gaps in the management of atrial fibrillation, ventricular tachycardia\/sudden death and heart failure.<\/jats:p>","DOI":"10.1093\/europace\/euz055","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T12:09:51Z","timestamp":1552651791000},"page":"993-994","source":"Crossref","is-referenced-by-count":48,"title":["EHRA White Paper: knowledge gaps in arrhythmia management\u2014status 2019"],"prefix":"10.1093","volume":"21","author":[{"given":"Andreas","family":"Goette","sequence":"first","affiliation":[{"name":"St. Vincenz-Krankenhaus GmbH, Cardiology and Intensive Care Medicine, Am Busdorf 2, Paderborn, Germany"},{"name":"Working Group Molecular Electrophysiology, University Hospital Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Auricchio","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fondazione Cardiocentro Ticino, Lugano (Ticino), Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"first","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieder","family":"Braunschweig","sequence":"first","affiliation":[{"name":"Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Brugada","family":"Terradellas","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hospital Clinic, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haran","family":"Burri","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Hospital of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A John","family":"Camm","sequence":"first","affiliation":[{"name":"St. George's, University of London, Molecular and Clinical Sciences Research Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Crijns","sequence":"first","affiliation":[{"name":"Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht UMC+, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Dagres","sequence":"first","affiliation":[{"name":"Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Deharo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Aix Marseille Universit\u00e9, CHU la Timone, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobromir","family":"Dobrev","sequence":"first","affiliation":[{"name":"University Duisburg-Essen, Institute of Pharmacology, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hatala","sequence":"first","affiliation":[{"name":"Department of Cardiology and Angiology, National Cardiovascular Institute, NUSCH, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hindricks","sequence":"first","affiliation":[{"name":"Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H","family":"Hohnloser","sequence":"first","affiliation":[{"name":"Division of Clinical Electrophysiology, Department of Cardiology, J.W. Goethe University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Leclercq","sequence":"first","affiliation":[{"name":"Univ Rennes, CHU Rennes, LTSI-UMR1099, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lewalter","sequence":"first","affiliation":[{"name":"Department of Cardiology and Intensive Care, Hospital for Internal Medicine Munich South, Munich, Germany"},{"name":"Department of Cardiology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"first","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Merino","sequence":"first","affiliation":[{"name":"Hospital Universitario La Paz, Arrhythmia and Robotic EP Unit, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Mont","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hospital Clinic, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"Prinzen","sequence":"first","affiliation":[{"name":"Department of Physiology, Maastricht University, Maastricht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Proclemer","sequence":"first","affiliation":[{"name":"Cardiology Division, University Hospital Udine, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"P\u00fcrerfellner","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ordensklinikum Linz Elisabethinen, Academic Teaching Hospital, Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Savelieva","sequence":"first","affiliation":[{"name":"St. George's, University of London, Molecular and Clinical Sciences Research Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Schilling","sequence":"first","affiliation":[{"name":"Barts Heart Centre, Barts and the London NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Steffel","sequence":"first","affiliation":[{"name":"University Heart Center Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle C","family":"van Gelder","sequence":"first","affiliation":[{"name":"Department Of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Zeppenfeld","sequence":"first","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center (Lumc), Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Zupan","sequence":"first","affiliation":[{"name":"Department Of Cardiology, University Clinical Centre Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Heidb\u00fcchel","sequence":"first","affiliation":[{"name":"Antwerp University and Antwerp University Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[{"name":"Cardiology Department, Clinique Pasteur, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Defaye","sequence":"additional","affiliation":[{"name":"CHU H\u00f4pital Albert Michalon, Unit\u00e9 de Rythmologie Service De Cardiologie, FR-38043 Grenoble Cedex 09, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Brignole","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ospedali Del Tigullio, Via Don Bobbio 25, IT-16033 Lavagna (GE), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongi","family":"Chun","sequence":"additional","affiliation":[{"name":"CCB, Cardiology Department, Med. Klinik Iii, Markuskrankenhaus, Wilhelm Epstein Str. 4, DE-60431 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M","family":"Guerra Ramos","sequence":"additional","affiliation":[{"name":"Unitat d'Aritmies, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Universit\u00e9 de Tours, Facult\u00e9 de M\u00e9decine, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Hastrup","family":"Svendsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassil B","family":"Traykov","sequence":"additional","affiliation":[{"name":"Department of Invasive Electrophysiology and Cardiac Pacing, Clinic of Cardiology, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank R","family":"Heinzel","sequence":"additional","affiliation":[{"name":"Charit\u00e9 University Medicine, Campus Virchow-Klinikum, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"2020041305460251300_euz055-B1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCRESAHA.117.311081","article-title":"Translational challenges in atrial fibrillation","volume":"122","author":"Heijman","year":"2018","journal-title":"Circ Res"},{"key":"2020041305460251300_euz055-B2","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","article-title":"Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression","volume":"114","author":"Heijman","year":"2014","journal-title":"Circ Res"},{"key":"2020041305460251300_euz055-B3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrcardio.2016.118","article-title":"Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation","volume":"13","author":"Nattel","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2020041305460251300_euz055-B4","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-019-0166-5","article-title":"Postoperative atrial fibrillation: mechanisms, manifestations and management","author":"Dobrev","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2020041305460251300_euz055-B5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.113.005421","article-title":"Driver domains in persistent atrial fibrillation","volume":"130","author":"Haissaguerre","year":"2014","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B6","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1113\/JP270513","article-title":"Mechanistically based mapping of human cardiac fibrillation","volume":"594","author":"Narayan","year":"2016","journal-title":"J Physiol"},{"key":"2020041305460251300_euz055-B7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.hrthm.2015.03.017","article-title":"Indices of bipolar complex fractionated atrial electrograms correlate poorly with each other and atrial fibrillation substrate complexity","volume":"12","author":"Lau","year":"2015","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/CIRCEP.115.003019","article-title":"Is there still a role for complex fractionated atrial electrogram ablation in addition to pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation? Meta-analysis of 1415 patients","volume":"8","author":"Providencia","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B9","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/CIRCRESAHA.116.310489","article-title":"Controversies about atrial fibrillation mechanisms: aiming for order in chaos and whether it matters","volume":"120","author":"Nattel","year":"2017","journal-title":"Circ Res"},{"key":"2020041305460251300_euz055-B10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jacep.2017.06.005","article-title":"Transient rotor activity during prolonged 3-dimensional phase mapping in human persistent atrial fibrillation","volume":"4","author":"Pathik","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nm1011","article-title":"Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia","volume":"10","author":"Ramanathan","year":"2004","journal-title":"Nat Med"},{"key":"2020041305460251300_euz055-B12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijcard.2017.02.152","article-title":"Spatial relationship of organized rotational and focal sources in human atrial fibrillation to autonomic ganglionated plexi","volume":"240","author":"Baykaner","year":"2017","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1053\/euhj.1999.1632","article-title":"Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes","volume":"20","author":"Viskin","year":"1999","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B14","doi-asserted-by":"crossref","first-page":":794","DOI":"10.1016\/S0002-9149(00)01509-5","article-title":"Circadian variation of paroxysmal atrial fibrillation. PA3 Investigators. Atrial Pacing Peri-ablation for Prevention of Atrial Fibrillation Trial","volume":"87","author":"Gillis","year":"2001","journal-title":"Am J Cardiol"},{"key":"2020041305460251300_euz055-B15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-8703(03)00405-8","article-title":"Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation","volume":"146","author":"Mitchell","year":"2003","journal-title":"Am Heart J"},{"key":"2020041305460251300_euz055-B16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2017.07.022","article-title":"Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease","volume":"248","author":"Nortamo","year":"2017","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B17","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B18","article-title":"Role of inflammatory signaling in atrial fibrillation","author":"Scott","year":"2018","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/cvr\/cvv275","article-title":"The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis","volume":"109","author":"Heijman","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2020041305460251300_euz055-B20","first-page":"11","article-title":"Antiarrhythmic drugs for atrial fibrillation: imminent impulses are emerging","volume":"21","author":"Dan","year":"2018","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2020041305460251300_euz055-B21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/HCO.0000000000000386","article-title":"Cardiac gene therapy with adeno-associated virus-based vectors","volume":"32","author":"Chamberlain","year":"2017","journal-title":"Curr Opin Cardiol"},{"key":"2020041305460251300_euz055-B22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","article-title":"Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality","volume":"114","author":"Zsebo","year":"2014","journal-title":"Circ Res"},{"key":"2020041305460251300_euz055-B23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCRESAHA.118.313811","article-title":"Atrial-specific gene delivery using an adeno-associated viral vector","volume":"124","author":"Ni","year":"2019","journal-title":"Circ Res"},{"key":"2020041305460251300_euz055-B24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004267","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)","volume":"10","author":"Link","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B27","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","article-title":"Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial","volume":"34","author":"Al-Khatib","year":"2013","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B28","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1161\/STROKEAHA.116.013746","article-title":"Higher risk of ischemic events in secondary prevention for patients with persistent than those with paroxysmal atrial fibrillation","volume":"47","author":"Koga","year":"2016","journal-title":"Stroke"},{"key":"2020041305460251300_euz055-B29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B30","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jacc.2014.04.019","article-title":"Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices","volume":"63","author":"Charitos","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B31","first-page":"CD012088","article-title":"Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation","volume":"11","author":"Nyong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2020041305460251300_euz055-B32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/eurheartj\/ehw260","article-title":"Catheter ablation in patients with persistent atrial fibrillation","volume":"38","author":"Kirchhof","year":"2017","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.hrthm.2015.12.007","article-title":"German ablation registry: cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation\u2014One-year outcome data","volume":"13","author":"Schmidt","year":"2016","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.hrthm.2017.01.038","article-title":"Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation","volume":"14","author":"Padfield","year":"2017","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10840-015-0029-x","article-title":"The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease?","volume":"44","author":"Veasey","year":"2015","journal-title":"J Interv Card Electrophysiol"},{"key":"2020041305460251300_euz055-B36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacep.2015.04.010","article-title":"A systematic review on the progression of paroxysmal to persistent atrial fibrillation: shedding new light on the effects of catheter ablation","volume":"1","author":"Proietti","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B38","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.chest.2017.08.004","article-title":"Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry","volume":"152","author":"Esato","year":"2017","journal-title":"Chest"},{"key":"2020041305460251300_euz055-B39","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1253\/circj.CJ-13-1272","article-title":"Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation","volume":"78","author":"Senoo","year":"2014","journal-title":"Circ J"},{"key":"2020041305460251300_euz055-B40","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.113.004742","article-title":"Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation","volume":"129","author":"Martins","year":"2014","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1536\/ihj.15-476","article-title":"Discrimination of paroxysmal and persistent atrial fibrillation in patients with new-onset atrial fibrillation","volume":"57","author":"Igarashi","year":"2016","journal-title":"Int Heart J"},{"key":"2020041305460251300_euz055-B42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/eurheartj\/ehx584","article-title":"A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score","volume":"39","author":"Hijazi","year":"2018","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008083","article-title":"Elevated circulating fibrocytes is a marker of left atrial fibrosis and recurrence of persistent atrial fibrillation","volume":"7","author":"Liu","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2020041305460251300_euz055-B44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2017.12.026","article-title":"The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation","volume":"103","author":"Stanciu","year":"2018","journal-title":"Cytokine"},{"key":"2020041305460251300_euz055-B45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jacc.2008.03.045","article-title":"Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover","volume":"52","author":"Kallergis","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B46","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/euhj.2000.2531","article-title":"Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function","volume":"22","author":"Li-Saw-Hee","year":"2001","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B47","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B48","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1006\/jmcc.2001.1389","article-title":"Expression and activity of ectopeptidases in fibrillating human atria","volume":"33","author":"Lendeckel","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"2020041305460251300_euz055-B49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacep.2015.12.014","article-title":"Persistent atrial fibrillation from the onset: a specific subgroup of patients with biatrial substrate involvement and poorer clinical outcome","volume":"2","author":"Lim","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B50","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijcard.2017.12.089","article-title":"Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation","volume":"257","author":"Masuda","year":"2018","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/pace.12264","article-title":"Evaluation of time course and predicting factors of progression of paroxysmal or persistent atrial fibrillation to permanent atrial fibrillation","volume":"37","author":"DE","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B53","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCEP.110.960153","article-title":"Differences in repeating patterns of complex fractionated left atrial electrograms in longstanding persistent atrial fibrillation as compared with paroxysmal atrial fibrillation","volume":"4","author":"Ciaccio","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/CIRCIMAGING.109.865683","article-title":"Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI","volume":"3","author":"Kuppahally","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"2020041305460251300_euz055-B55","doi-asserted-by":"crossref","first-page":"f288","DOI":"10.1093\/europace\/eux178","article-title":"Temporal pattern\/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management?","volume":"20","author":"Hammond-Haley","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B56","doi-asserted-by":"crossref","first-page":"e000916.","DOI":"10.1161\/JAHA.114.000916","article-title":"Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation","volume":"3","author":"Sandhu","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2020041305460251300_euz055-B57","article-title":"Clinical importance of atrial cardiomyopathy","author":"Hammwohner","year":"2018","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B58","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehu028","article-title":"Early management of atrial fibrillation to prevent cardiovascular complications","volume":"35","author":"Nattel","year":"2014","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/europace\/eux318","article-title":"Integrating new approaches to atrial fibrillation management: the 6th AFNET\/EHRA Consensus Conference","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B60","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2012.05.017","article-title":"A proposal for new clinical concepts in the management of atrial fibrillation","volume":"164","author":"Camm","year":"2012","journal-title":"Am Heart J"},{"key":"2020041305460251300_euz055-B61","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.116.026693","article-title":"Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration","volume":"135","author":"Freedman","year":"2017","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.2018.4190","article-title":"Screening for atrial fibrillation with electrocardiography: evidence report and systematic review for the US Preventive Services Task Force","volume":"320","author":"Jonas","year":"2018","journal-title":"JAMA"},{"key":"2020041305460251300_euz055-B63","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/CIRCULATIONAHA.112.126656","article-title":"Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention","volume":"127","author":"Engdahl","year":"2013","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH13-02-0165","article-title":"Screening to identify unknown atrial fibrillation","volume":"110","author":"Lowres","year":"2013","journal-title":"Thromb Haemost"},{"key":"2020041305460251300_euz055-B65","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2018.8102","article-title":"Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial","volume":"320","author":"Steinhubl","year":"2018","journal-title":"JAMA"},{"key":"2020041305460251300_euz055-B66","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass screening for untreated atrial fibrillation: the STROKESTOP study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B68","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/STROKEAHA.109.571455","article-title":"Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events","volume":"41","author":"Ziegler","year":"2010","journal-title":"Stroke"},{"key":"2020041305460251300_euz055-B69","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/europace\/eux163","article-title":"Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B70","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/europace\/eux177","article-title":"Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)","volume":"19","author":"Mairesse","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pharmthera.2004.01.001","article-title":"Nonchannel drug targets in atrial fibrillation","volume":"102","author":"Goette","year":"2004","journal-title":"Pharmacol Ther"},{"key":"2020041305460251300_euz055-B72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/europace\/eum283","article-title":"Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms","volume":"10","author":"Goette","year":"2008","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B73","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2018.11.133","article-title":"Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany","volume":"278","author":"Ehrlich","year":"2019","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B74","article-title":"Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: a subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial","author":"Cohen","year":"2018","journal-title":"Am Heart J"},{"key":"2020041305460251300_euz055-B75","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"2020041305460251300_euz055-B76","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"2020041305460251300_euz055-B77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2010.09.004","article-title":"The impact of rapid atrial pacing on ADMA and endothelial NOS","volume":"154","author":"Goette","year":"2012","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.amjcard.2017.10.008","article-title":"Impact of body mass index on outcomes in the edoxaban versus warfarin therapy groups in patients underwent cardioversion of atrial fibrillation (from ENSURE-AF)","volume":"121","author":"Lip","year":"2018","journal-title":"Am J Cardiol"},{"key":"2020041305460251300_euz055-B79","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2017.07.033","article-title":"CREM-transgene mice: an animal model of atrial fibrillation and thrombogenesis","volume":"163","author":"Bukowska","year":"2018","journal-title":"Thromb Res"},{"key":"2020041305460251300_euz055-B80","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ehjci\/jex322","article-title":"Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation","volume":"19","author":"Galderisi","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2020041305460251300_euz055-B81","doi-asserted-by":"crossref","first-page":"e017157.","DOI":"10.1136\/bmjopen-2017-017157","article-title":"Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation","volume":"7","author":"Fox","year":"2017","journal-title":"BMJ Open"},{"key":"2020041305460251300_euz055-B82","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2020041305460251300_euz055-B83","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B84","doi-asserted-by":"crossref","first-page":"e0181000.","DOI":"10.1371\/journal.pone.0181000","article-title":"Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: a retrospective register study","volume":"12","author":"Sjogren","year":"2017","journal-title":"PLoS One"},{"key":"2020041305460251300_euz055-B85","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/j.1540-8159.2000.tb07041.x","article-title":"Increased expression of P-selectin in patients with chronic atrial fibrillation","volume":"23","author":"Goette","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B86","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B87","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/hrt.2005.087171","article-title":"Cigarette smoking induces atrial fibrosis in humans via nicotine","volume":"93","author":"Goette","year":"2007","journal-title":"Heart"},{"key":"2020041305460251300_euz055-B88","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B89","author":"Packer","year":"2018"},{"key":"2020041305460251300_euz055-B90","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B91","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1093\/eurheartj\/ehy555","article-title":"A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B92","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B93","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation","volume":"372","author":"Verma","year":"2015","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B94","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.114.014092","article-title":"Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) study","volume":"132","author":"Reddy","year":"2015","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B95","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","article-title":"Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial","volume":"129","author":"Di","year":"2014","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B96","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/pace.12481","article-title":"Comparison of different approaches to atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation","volume":"37","author":"Arenja","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1540-8159.1994.tb01352.x","article-title":"Radiofrequency catheter atrioventricular node ablation in patients with permanent cardiac pacing systems","volume":"17","author":"Chang","year":"1994","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/pace.12525","article-title":"Long-term follow-up in AV junction ablation via the SVC in patients undergoing concurrent device implantation: a single center experience","volume":"38","author":"Issa","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B99","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1540-8159.2000.tb00887.x","article-title":"Safety of pacemaker implantation prior to radiofrequency ablation of atrioventricular junction in a single session procedure","volume":"23","author":"Proclemer","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1009795330454","article-title":"The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators","volume":"2","author":"Kay","year":"1998","journal-title":"J Interv Card Electrophysiol"},{"key":"2020041305460251300_euz055-B101","first-page":"186","article-title":"Simultaneous atrioventricular node ablation and leadless pacemaker implantation","volume":"3","author":"Ho","year":"2017","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B102","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/pace.13312","article-title":"Leadless pacemaker implantation and concurrent atrioventricular junction ablation in patients with atrial fibrillation","volume":"41","author":"Okabe","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B103","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/europace\/eun197","article-title":"Radiofrequency ablation of drug-refractory atrial fibrillation: an observational study comparing \u2018ablate and pace\u2019 with pulmonary vein isolation","volume":"10","author":"Proclemer","year":"2008","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B104","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1540-8167.2005.40632.x","article-title":"Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation","volume":"16","author":"Hsieh","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2020041305460251300_euz055-B105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/pace.12340","article-title":"Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?","volume":"37","author":"Chen","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B106","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/hrt.2009.188425","article-title":"The evaluation of pulmonary vein isolation and wide-area left atrial ablation to treat atrial fibrillation in patients with implanted permanent pacemakers: the Previously Paced Pulmonary Vein Isolation Study","volume":"96","author":"Veasey","year":"2010","journal-title":"Heart"},{"key":"2020041305460251300_euz055-B107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1540-8159.1998.tb00092.x","article-title":"Scoring method for assessing rate adaptive pacemakers: application to two different activity sensors","volume":"21","author":"Garrigue","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B108","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/j.1540-8159.1996.tb03181.x","article-title":"Dual sensor VVIR mode pacing: is it worth it?","volume":"19","author":"Sulke","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B109","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1540-8159.2008.01207.x","article-title":"A blended sensor restores chronotropic response more favorably than an accelerometer alone in pacemaker patients: the LIFE study results","volume":"31","author":"Coman","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/europace\/eun024","article-title":"Closed loop stimulation and accelerometer-based rate adaptation: results of the PROVIDE study","volume":"10","author":"Coenen","year":"2008","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B111","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1460-9592.2002.00967.x","article-title":"Automatic mode switching of implantable pacemakers: I. Principles of instrumentation, clinical, and hemodynamic considerations","volume":"25","author":"Lau","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B112","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/oxfordjournals.eurheartj.a060413","article-title":"Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life","volume":"15","author":"Lau","year":"1994","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B113","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1460-9592.2003.00039.x","article-title":"Advanced pacemaker diagnostic features in the characterization of atrial fibrillation: impact on preventive pacing algorithms","volume":"26","author":"Yang","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B114","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hrthm.2016.11.033","article-title":"Variability in obstructive sleep apnea: analysis of pacemaker-detected respiratory disturbances","volume":"14","author":"Moubarak","year":"2017","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B115","first-page":"1500","article-title":"Clinically guided pacemaker choice and setting: pacemaker expert programming study","volume":"19","author":"Ziacchi","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B116","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2006.01.056","article-title":"Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing","volume":"47","author":"Occhetta","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B117","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005309","article-title":"Benefits of permanent His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction","volume":"6","author":"Huang","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2020041305460251300_euz055-B118","doi-asserted-by":"crossref","first-page":"iv10","DOI":"10.1093\/europace\/eux263","article-title":"Atrioventricular node ablation and His bundle pacing","volume":"19","author":"Vijayaraman","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B119","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.CIR.101.8.869","article-title":"Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation","volume":"101","author":"Deshmukh","year":"2000","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B120","first-page":"323","article-title":"Permanent His bundle pacing at the time of atrioventricular node ablation: a 3-dimensional mapping approach","volume":"3","author":"Ringwala","year":"2017","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B121","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.hrthm.2013.01.021","article-title":"Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation","volume":"10","author":"Wang","year":"2013","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B122","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1540-8159.1997.tb06179.x","article-title":"Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction","volume":"20","author":"Geelen","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B123","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/hc3301.094739","article-title":"Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator","volume":"104","author":"Adler","year":"2001","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B124","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1540-8167.2001.01121.x","article-title":"Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy","volume":"12","author":"Israel","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2020041305460251300_euz055-B125","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0735-1097(02)02345-8","article-title":"Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator","volume":"40","author":"Gillis","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B126","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0735-1097(03)00426-1","article-title":"The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias","volume":"41","author":"Lee","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B127","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1099-5129(03)00082-5","article-title":"Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden","volume":"5","author":"Hugl","year":"2003","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B128","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/eurheartj\/ehu165","article-title":"Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B129","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.hrthm.2015.04.015","article-title":"New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: results from the MINERVA randomized multicenter international trial","volume":"12","author":"Padeletti","year":"2015","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B130","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.hrthm.2015.02.017","article-title":"Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: an analysis of the randomized MINERVA trial","volume":"12","author":"Boriani","year":"2015","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrcardio.2015.30","article-title":"Management of atrial fibrillation in bradyarrhythmias","volume":"12","author":"Boriani","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2020041305460251300_euz055-B132","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.hrthm.2017.05.023","article-title":"Atrial antitachycardia pacing and atrial remodeling: a substudy of the international, randomized MINERVA trial","volume":"14","author":"Boriani","year":"2017","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B133","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ahj.2008.05.004","article-title":"The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias","volume":"156","author":"Funck","year":"2008","journal-title":"Am Heart J"},{"key":"2020041305460251300_euz055-B134","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/ejhf.1117","article-title":"Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations","volume":"20","author":"Gasparini","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2020041305460251300_euz055-B135","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ejhf.269","article-title":"Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID-CRT risk score","volume":"17","author":"Gasparini","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2020041305460251300_euz055-B136","doi-asserted-by":"crossref","first-page":"iii262.","DOI":"10.1093\/ehjci\/eux156.008","article-title":"Effectiveness of a reactive atrial antitachycardia pacing feature in patients with ICDs: a large database analysis","volume":"19","author":"Boriani","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B137","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00399-016-0459-x","article-title":"Optimal tachycardia programming in ICDs: recommendations in the post-MADIT-RIT era","volume":"27","author":"Israel","year":"2016","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"2020041305460251300_euz055-B138","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/europace\/euv411","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"18","author":"Wilkoff","year":"2016","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B139","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2459\/JCM.0000000000000630","article-title":"Clinically oriented device programming in bradycardia patients: part 1 (sinus node disease). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing)","volume":"19","author":"Ziacchi","year":"2018","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2020041305460251300_euz055-B140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2459\/JCM.0000000000000629","article-title":"Clinically oriented device programming in bradycardia patients: part 2 (atrioventricular blocks and neurally mediated syncope). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing)","volume":"19","author":"Palmisano","year":"2018","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2020041305460251300_euz055-B141","first-page":"414","article-title":"Effect of fixed-rate vs. rate-RESPONSIve pacing on exercise capacity in patients with permanent, refractory atrial fibrillation and left ventricular dysfunction treated with atrioventricular junction aBLation and bivEntricular pacing (RESPONSIBLE): a prospective, multicentre, randomized, single-blind study","volume":"19","author":"Palmisano","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B142","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCEP.113.001217","article-title":"Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis","volume":"7","author":"Tan","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B143","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/europace\/euw415","article-title":"Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis","volume":"19","author":"Auricchio","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B144","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jchf.2013.06.003","article-title":"Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry)","volume":"1","author":"Gasparini","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2020041305460251300_euz055-B145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jacc.2013.07.105","article-title":"Avoiding unnecessary aggressive ICD programming after MADIT-RIT and ADVANCE III trials","volume":"63","author":"Gasparini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B146","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/europace\/euw032","article-title":"Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial","volume":"18","author":"Arenal","year":"2016","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B147","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.hrthm.2015.12.032","article-title":"Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy)","volume":"13","author":"Biton","year":"2016","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B148","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.joa.2015.11.007","article-title":"Atrial arrhythmias in inherited arrhythmogenic disorders","volume":"32","author":"Hasdemir","year":"2016","journal-title":"J Arrhythm"},{"key":"2020041305460251300_euz055-B149","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: cardiomyopathies that look alike","volume":"55","author":"Seward","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B150","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.recesp.2017.05.018","article-title":"Diagnosis and treatment of transthyretin cardiac amyloidosis. Progress and hope","volume":"70","author":"Gonzalez-Lopez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2020041305460251300_euz055-B151","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ehf2.12308","article-title":"Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience","volume":"5","author":"Mints","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2020041305460251300_euz055-B152","first-page":"1204","article-title":"Cardiac arrhythmias in patients with Danon disease","volume":"19","author":"Konrad","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B153","first-page":"1288.","article-title":"Atrial fibrillation in cardiac sarcoidosis","volume":"8","author":"Mehta","year":"2015","journal-title":"J Atr Fibrillation"},{"key":"2020041305460251300_euz055-B154","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/hrt.2010.196162","article-title":"Atrial biopsy evidence of Fabry disease causing lone atrial fibrillation","volume":"96","author":"Chimenti","year":"2010","journal-title":"Heart"},{"key":"2020041305460251300_euz055-B155","doi-asserted-by":"crossref","first-page":"777.","DOI":"10.1136\/hrt.2006.090530","article-title":"Wegener's granulomatosis with progressive conduction disturbances and atrial fibrillation","volume":"93","author":"Lim","year":"2007","journal-title":"Heart"},{"key":"2020041305460251300_euz055-B156","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.hrthm.2008.02.007","article-title":"Prevalence of early-onset atrial fibrillation in congenital long QT syndrome","volume":"5","author":"Johnson","year":"2008","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B157","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1046\/j.1540-8167.2003.03165.x","article-title":"Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome","volume":"14","author":"Kirchhof","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2020041305460251300_euz055-B158","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1093\/eurheartj\/ehp326","article-title":"New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance","volume":"30","author":"Pappone","year":"2009","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B159","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2007.10.062","article-title":"Atrial fibrillation and Brugada syndrome","volume":"51","author":"Francis","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.hrthm.2006.12.048","article-title":"Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Napolitano","year":"2007","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B161","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.hrthm.2016.06.008","article-title":"Atrial fibrillation in inherited cardiac channelopathies: from mechanisms to management","volume":"13","author":"Enriquez","year":"2016","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B162","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"Al-Khatib","year":"2017","journal-title":"J Am Coll Cardiol 2018"},{"key":"2020041305460251300_euz055-B163","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jamacardio.2017.0266","article-title":"Sudden cardiac arrest risk assessment: population science and the individual risk mandate","volume":"2","author":"Myerburg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2020041305460251300_euz055-B164","doi-asserted-by":"crossref","first-page":"f249","DOI":"10.1093\/europace\/euy112","article-title":"Management of patients with ventricular arrhythmias and prevention of sudden cardiac death-translating guidelines into practice: results of the European Heart Rhythm Association survey","volume":"20","author":"Haugaa","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B165","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ijcard.2012.12.042","article-title":"Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study","volume":"168","author":"Proclemer","year":"2013","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B166","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jcmg.2016.01.033","article-title":"Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis","volume":"9","author":"Disertori","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2020041305460251300_euz055-B167","first-page":"1601","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B168","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2020041305460251300_euz055-B169","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2018.1116","article-title":"Management of ventricular arrhythmias and sudden cardiac death risk associated with cardiac channelopathies","volume":"3","author":"Al-Khatib","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2020041305460251300_euz055-B170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B171","article-title":"German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management","author":"Thomas","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2020041305460251300_euz055-B172","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2016.10.025","article-title":"Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: the SHIELD-2 trial","volume":"185","author":"Robinson","year":"2017","journal-title":"Am Heart J"},{"key":"2020041305460251300_euz055-B173","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1535370218788517","article-title":"Integration of \u201comics\u201d techniques: dronedarone affects cardiac remodeling in the infarction border zone","volume":"243","author":"Chilukoti","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"2020041305460251300_euz055-B174","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2017.03.053","article-title":"Devices for management of sudden cardiac death: successes, challenges and perspectives","volume":"237","author":"Dagres","year":"2017","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B175","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B176","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/eht109","article-title":"Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?","volume":"34","author":"Dagres","year":"2013","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B177","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/europace\/eux258","article-title":"A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 report from the European Heart Rhythm Association","volume":"19","author":"Raatikainen","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B178","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2007.08.058","article-title":"Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B179","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B180","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/eurheartj\/ehn540","article-title":"Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk)","volume":"30","author":"Bauer","year":"2009","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B181","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/eurheartj\/ehi188","article-title":"Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era","volume":"26","author":"Makikallio","year":"2005","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B182","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/CIRCULATIONAHA.111.023846","article-title":"Sudden cardiac death caused by coronary heart disease","volume":"125","author":"Myerburg","year":"2012","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B183","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B184","doi-asserted-by":"crossref","first-page":"f217","DOI":"10.1093\/europace\/euy077","article-title":"Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study","volume":"20","author":"Ruwald","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B185","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B186","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/europace\/eux089","article-title":"Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey","volume":"19","author":"Haugaa","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B187","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hrthm.2016.11.025","article-title":"Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B188","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/euy009","article-title":"Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey","volume":"20","author":"Boveda","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B189","doi-asserted-by":"crossref","first-page":"f240","DOI":"10.1093\/europace\/euy083","article-title":"Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies","volume":"20","author":"Brouwer","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B190","doi-asserted-by":"crossref","first-page":"1217.","DOI":"10.1093\/europace\/euy050","article-title":"2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS\/HRS\/LAHRS","volume":"20","author":"Bongiorni","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B191","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.hrthm.2017.05.005","article-title":"Compliant endovascular balloon reduces the lethality of superior vena cava tears during transvenous lead extractions","volume":"14","author":"Azarrafiy","year":"2017","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B192","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.hrthm.2009.05.020","article-title":"Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA)","volume":"6","author":"Wilkoff","year":"2009","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B193","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1016\/j.hrthm.2017.09.001","article-title":"2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction","volume":"14","author":"Kusumoto","year":"2017","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B194","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/europace\/eut425","article-title":"Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads","volume":"16","author":"Burri","year":"2014","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"key":"2020041305460251300_euz055-B196","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B197","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B198","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2015.10.026","article-title":"Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial","volume":"66","author":"Di Biase","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B199","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.003901","article-title":"Impact of new technologies and approaches for post-myocardial infarction ventricular tachycardia ablation during long-term follow-up","volume":"9","author":"Yamashita","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B200","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/europace\/euw406","article-title":"Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study","volume":"20","author":"Acosta","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B201","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/eurheartj\/ehx227","article-title":"Remote management of heart failure using implantable electronic devices","volume":"38","author":"Morgan","year":"2017","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B202","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"2020041305460251300_euz055-B203","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(14)61176-4","article-title":"Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial","volume":"384","author":"Hindricks","year":"2014","journal-title":"Lancet"},{"key":"2020041305460251300_euz055-B204","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B205","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"2020041305460251300_euz055-B206","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"Khand","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B207","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"PIONEER-HF Investigators. Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B208","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2018","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B209","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/europace\/euy152","article-title":"Cardiac resynchronization therapy in heart failure: is the defibrillator needed?","volume":"20","author":"Dagres","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2018.03.087","article-title":"Cardiac resynchronization therapy in the ageing population\u2014with or without an implantable defibrillator?","volume":"263","author":"Doring","year":"2018","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B211","first-page":"1357","article-title":"Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting","volume":"19","author":"Laish-Farkash","year":"2017","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B212","article-title":"Survival after cardiac resynchronization therapy: results from 50 084 implantations","author":"Leyva","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B213","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/eurheartj\/ehx015","article-title":"Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST)","volume":"38","author":"Hindricks","year":"2017","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B214","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCULATIONAHA.108.800490","article-title":"Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure","volume":"121","author":"Ritzema","year":"2010","journal-title":"Circulation"},{"key":"2020041305460251300_euz055-B215","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"2020041305460251300_euz055-B216","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-017-9652-1","article-title":"De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis","volume":"23","author":"Kosztin","year":"2018","journal-title":"Heart Fail Rev"},{"key":"2020041305460251300_euz055-B217","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/europace\/eux323","article-title":"Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis","volume":"20","author":"Narducci","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B218","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/cvr\/cvy182","article-title":"Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis","volume":"114","author":"Deif","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2020041305460251300_euz055-B219","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ejhf.1235","article-title":"Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II","volume":"20","author":"Linde","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2020041305460251300_euz055-B220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jacep.2017.10.002","article-title":"Reversal of pacing-induced cardiomyopathy following cardiac resynchronization therapy","volume":"4","author":"Khurshid","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B221","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/CIRCEP.113.001299","article-title":"PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy","volume":"7","author":"Kutyifa","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B222","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00392-016-1003-z","article-title":"Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up","volume":"105","author":"Stockburger","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2020041305460251300_euz055-B223","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10840-015-9999-y","article-title":"Impact of baseline PR interval on cardiac resynchronization therapy outcomes in patients with narrow QRS complexes: an analysis of the ReThinQ trial","volume":"43","author":"Joshi","year":"2015","journal-title":"J Interv Card Electrophysiol"},{"key":"2020041305460251300_euz055-B224","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1093\/eurheartj\/ehv723","article-title":"ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy","volume":"37","author":"Morgan","year":"2016","journal-title":"Eur Heart J"},{"key":"2020041305460251300_euz055-B225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/europace\/eut435","article-title":"Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study","volume":"16","author":"Auricchio","year":"2014","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B226","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.jacc.2017.02.059","article-title":"Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the SELECT-LV study","volume":"69","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B227","doi-asserted-by":"crossref","first-page":"e003344.","DOI":"10.1161\/CIRCEP.115.003344","article-title":"Feasibility and acute hemodynamic effect of left ventricular septal pacing by transvenous approach through the interventricular septum","volume":"9","author":"Mafi-Rad","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B228","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hrthm.2017.10.014","article-title":"Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: a multicenter experience","volume":"15","author":"Sharma","year":"2018","journal-title":"Heart Rhythm"},{"key":"2020041305460251300_euz055-B229","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/heartjnl-2018-313415","article-title":"Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block","volume":"105","author":"Huang","year":"2019","journal-title":"Heart"},{"key":"2020041305460251300_euz055-B230","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.jacc.2016.02.051","article-title":"Improvement in clinical outcomes with biventricular versus right ventricular pacing: the BLOCK HF study","volume":"67","author":"Curtis","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B231","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/europace\/eul075","article-title":"Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the \u2018Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)\u2019 study","volume":"8","author":"Funck","year":"2006","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B232","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/europace\/euy058","article-title":"Permanent His-bundle pacing: a systematic literature review and meta-analysis","volume":"20","author":"Zanon","year":"2018","journal-title":"Europace"},{"key":"2020041305460251300_euz055-B233","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2018.02.048","article-title":"Clinical outcomes of His bundle pacing compared to right ventricular pacing","volume":"71","author":"Abdelrahman","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B234","doi-asserted-by":"crossref","first-page":"1501.","DOI":"10.4022\/jafib.1501","article-title":"His bundle pacing or biventricular pacing for cardiac resynchronization therapy in heart failure: discovering new methods for an old problem","volume":"9","author":"Sharma","year":"2016","journal-title":"J Atr Fibrillation"},{"key":"2020041305460251300_euz055-B235","first-page":"59","article-title":"Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure","volume":"21","author":"Pomini","year":"1991","journal-title":"G Ital Cardiol"},{"key":"2020041305460251300_euz055-B236","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1213\/XAA.0000000000000490","article-title":"Mechanical support with impella during malignant arrhythmia ablation: a case report on the growing trend in the electrophysiology laboratory","volume":"8","author":"Adler","year":"2017","journal-title":"A A Case Rep"},{"key":"2020041305460251300_euz055-B237","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jacep.2017.07.005","article-title":"Hemodynamic support in ventricular tachycardia ablation: an international VT Ablation Center Collaborative Group Study","volume":"3","author":"Turagam","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B238","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004717","article-title":"Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices","volume":"10","author":"Kusa","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B239","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCEP.112.975888","article-title":"Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1)","volume":"6","author":"Miller","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020041305460251300_euz055-B240","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacep.2016.03.009","article-title":"Atrial fibrillation in patients with left ventricular assist devices: incidence, predictors, and clinical outcomes","volume":"2","author":"Hickey","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B241","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jtcvs.2018.03.169","article-title":"Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement","volume":"156","author":"Hawkins","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2020041305460251300_euz055-B242","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005340","article-title":"Atrial arrhythmias and electroanatomical remodeling in patients with left ventricular assist devices","volume":"6","author":"Deshmukh","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2020041305460251300_euz055-B243","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.acvd.2017.07.006","article-title":"Electrical storm in the early phase of HeartMate((R)) II device implantation: incidence, risk factors and prognosis","volume":"111","author":"Corre","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"2020041305460251300_euz055-B244","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jacep.2017.05.012","article-title":"Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience","volume":"3","author":"Moss","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2020041305460251300_euz055-B245","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jchf.2017.08.014","article-title":"Implantable cardioverter-defibrillators in patients with a continuous-flow left ventricular assist device: an analysis of the INTERMACS Registry","volume":"5","author":"Clerkin","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2020041305460251300_euz055-B246","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2016.07.257","article-title":"The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices\u2014a meta-analysis","volume":"222","author":"Agrawal","year":"2016","journal-title":"Int J Cardiol"},{"key":"2020041305460251300_euz055-B247","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2020041305460251300_euz055-B248","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007748","article-title":"Prospective randomized evaluation of implantable cardioverter-defibrillator programming in patients with a left ventricular assist device","volume":"7","author":"Richardson","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/21\/7\/993\/33024787\/euz055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/21\/7\/993\/33024787\/euz055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T09:48:12Z","timestamp":1586771292000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/21\/7\/993\/5382305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":248,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,3,18]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euz055","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,3,18]]}}}